IMMR financial statements and SEC filings
IMMR annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2026-04-30 | $1.73B | $25.91M | $4.52M | 10-K |
| 2025-04-30 | $1.56B | $118.02M | $62.66M | 10-K |
| 2023-12-31 | $33.92M | $17.93M | $33.98M | 10-K |
| 2022-12-31 | $38.46M | $24.42M | $30.66M | 10-K |
| 2021-12-31 | $35.09M | $17.77M | $12.48M | 10-K |
| 2020-12-31 | $30.46M | $2.22M | $5.40M | 10-K |
IMMR annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2026-04-30 | $1.05B | $484.94M | $567.40M | 10-Q |
| 2025-04-30 | $1.10B | $543.58M | $558.70M | 10-K |
| 2023-12-31 | $215.73M | $32.63M | $183.10M | 10-QT |
| 2022-12-31 | $190.11M | $32.41M | $157.70M | 10-K |
| 2021-12-31 | $175.52M | $34.23M | $141.29M | 10-K |
| 2020-12-31 | $96.13M | $32.15M | $63.98M | 10-K |
IMMR annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2026-04-30 | $59.07M | -$16.20M | -$44.75M | 10-K |
| 2025-04-30 | -$57.58M | -$11.24M | $60.95M | 10-K |
| 2023-12-31 | $20.60M | $0.00 | -$16.75M | 10-K |
| 2022-12-31 | $40.15M | -$30.00K | -$13.41M | 10-K |
| 2021-12-31 | $17.45M | -$335.00K | $62.20M | 10-K |
| 2020-12-31 | $22.00K | -$47.00K | -$29.93M | 10-K |